USA – Covid Put Remote Abortion to the Test. Supporters Say It Passed.

Medication abortion was briefly available online in some states, but a court ruling blocked it. Advocates want it back.

BY REBECCA GRANT
04.05.2021

LAST SUMMER, Cindy Adam and Lauren Dubey received the news they had hoped for, but hadn’t expected to get so soon. Their new telemedicine clinic would be able to offer remote medication abortion services, at least for the time being.

Medication abortion — which most commonly involves taking two medications, 24 to 48 hours apart, during the first 10 weeks of pregnancy — has been available in the U.S. since 2000. But, despite a growing chorus of advocates and experts who say remote access is just as safe as in-clinic care, the Food and Drug Administration requires providers to dispense mifepristone, the first of the two medications, inside the walls of a clinic, hospital, or medical office, citing the risk of complications. Most abortion providers interpreted this language to mean they could not mail mifepristone to patients’ homes, rendering fully remote abortion care impossible.

Continued: https://undark.org/2021/04/05/digital-abortion-access/


U.S.-Based Online Pharmacy First to Ship Abortion Pills to Patients Inside the U.S.

9/30/2020
by CARRIE N. BAKER

For years, pharmacies outside the U.S. have been shipping abortion pills to American women wanting to end their pregnancies. But now, for the first time, a U.S.-based pharmacy—Honeybee Health—is distributing abortion pills directly to patients within the country by mail, now legal because of a recent federal court ruling.

“This is a momentous achievement for Americans, particularly for women of color and others who historically faced barriers to reproductive healthcare that are made even worse by COVID-19,” said Dr. Jessica Nouhavandi, co-founder, co-CEO and lead pharmacist of Honeybee Health.

Continued: https://msmagazine.com/2020/09/30/honeybee-health-us-based-online-pharmacy-first-to-ship-abortion-pills-to-patients-inside-the-u-s/


USA – Medication Abortion and Telemedicine: Innovations and Barriers During the COVID-19 Emergency

Medication Abortion and Telemedicine: Innovations and Barriers During the COVID-19 Emergency

Amrutha Ramaswamy, Gabriela Weigel, Laurie Sobel
Jun 08, 2020

State actions in response to the COVID-19 crisis have highlighted their divergent approaches to abortion access. Some states classified abortion as a non-essential service, effectively banning services, while others have clarified that abortion is an essential service. In a handful of states, some clinics have begun to offer medication abortions using telemedicine. This approach maintains access to abortion while social distancing, preserving personal protective equipment (PPE), and limiting in-person health care visits and risk of exposure.

In 2017, 39% of all abortions in the U.S. were medication abortions (also known as abortions induced by pills). These abortions are provided using two medications, mifepristone and misoprostol. While public knowledge about medication abortion is very low, even fewer people may be aware that telemedicine can aid in the provision of this service. Research shows that providing medication abortion by telemedicine is clinically feasible and safe, but COVID-19 has highlighted the impact of new and existing federal and state restrictions on providing abortions using this approach.

Continued: https://www.kff.org/coronavirus-policy-watch/medication-abortion-telemedicine-innovations-and-barriers-during-the-covid-19-emergency/